{
    "organizations": [],
    "uuid": "bccdc0e3c83a5dba426f78ba1675554e11319310",
    "author": "",
    "url": "https://www.reuters.com/article/brief-eleven-biotherapeutics-announces-p/brief-eleven-biotherapeutics-announces-pricing-of-10-0-million-offering-priced-at-the-market-idUSASC09T6F",
    "ord_in_thread": 0,
    "title": "BRIEF-Eleven Biotherapeutics Announces Pricing Of $10.0 Million Offering Priced At-The-Market",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 21, 2018 / 1:41 PM / Updated 26 minutes ago BRIEF-Eleven Biotherapeutics Announces Pricing Of $10.0 Million Offering Priced At-The-Market Reuters Staff Eleven Biotherapeutics Inc: * ELEVEN BIOTHERAPEUTICS ANNOUNCES PRICING OF $10.0 MILLION OFFERING PRICED AT-THE-MARKET * ELEVEN BIOTHERAPEUTICS - ENTERED DEFINITIVE AGREEMENT WITH SEVERAL INVESTORS FOR PURCHASE OF ABOUT 8 MILLION SHARES OF ITS COMMON STOCK AT $1.13PER SHARE Source text for Eikon: Further company coverage:",
    "published": "2018-03-21T15:38:00.000+02:00",
    "crawled": "2018-03-21T16:20:15.087+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "biotherapeutics",
        "announces",
        "pricing",
        "million",
        "offering",
        "priced",
        "reuters",
        "staff",
        "eleven",
        "biotherapeutics",
        "inc",
        "eleven",
        "biotherapeutics",
        "announces",
        "pricing",
        "million",
        "offering",
        "priced",
        "eleven",
        "biotherapeutics",
        "entered",
        "definitive",
        "agreement",
        "several",
        "investor",
        "purchase",
        "million",
        "share",
        "common",
        "stock",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}